Endoglin a novel potential marker of atherogenesis is expressed in advanced atherosclerotic lesions and affected by atorvastatin treatment in ApoE/LDLR-deficient mice
Evaluation of the expression of endoglin in atherosclerotic plaques, its co-localization with vascular cell adhesion molecule (VCAM-1) and whether it is affected by atorvastatin treatment in apoE/LDLR deficient mice